The New Twist In Regeneron's 23andMe Bankruptcy Buyout - Investor's Business Daily
07.06.2025 02:45
Bankrupt genetics company 23andMe (MEHCQ) wants to reopen bidding on its assets after former Chief Executive Anne Wojcicki put together a $305 million offer, topping Regeneron Pharmaceuticals (REGN).… [+1973 chars]